Market Reports Center

BIOTECHNOLOGY


Expert analysis of leading-edge industry technologies involved in drug discovery, drug delivery, systems biology, proteomics, genomics, high-throughput screening, genetic diseases, nanotechnology, immunoassays or other biotech and pharmaceutical applications. The research reports from this category offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.

Total 187 Reports Found - Showing Reports From 1 To 25

Everyday exposure to ecological microorganisms (receptive oxygen species, methylating operators, UV light, and other radiation) exposure to natural specialists and typical physiological procedures (replication and recombination) all harm DNA. Cells must repair the damaged DNA to prevent it from further mutations and to keep up genome integrity and stability. There are different types of DNA repair mechanisms including non-homologous end joining, homologous recombination, mismatch repair and nucl

View Details

DNA library preparation kit is collectively set of improved reagents which are used to convert the small amount of DNA into indexed libraries. DNA library kits are used in next-generation sequencing for conversion of small amount of DNA. DNA library preparation kits are developed on the basis of Tn5 Transposase. DNA library preparation kits help during the complex process of DNA fragmentation and also for adaptor connection into a one-step enzymatic reaction. Therefore, these kits have significa

View Details

Among the different product type segments of the global DNA and RNA sample preparation market, the Kits segment dominated the global DNA and RNA sample preparation market in revenue terms in 2017 and is projected to continue to do so throughout the forecast period.The advantages of kits over other sample preparation products include minimal DNA loss, recovery of high molecular weight DNA, improved reliability and reproducibility. Scope of the Report: This report studies the DNA And RNA Samp

View Details

DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases. Scope of the Report: This report studies the DNA Testing/Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the DNA Testing/Diagnostics market by product type and applications/end industries. With the rising incidence

View Details

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are com

View Details

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect. Cancer stem cells (CSCs) are cancer cells that have all the

View Details

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs. Scope of the Report: This report focuses on the Spine Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. North Ame

View Details

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bact

View Details

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, especially in North Am

View Details

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and ven

View Details

Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expa

View Details

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categoriz

View Details

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Kohler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological re

View Details

Genome Editing/Genome Engineering Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Genome Editing/Genome Engineering basics: definitions, classifications, applications and market

View Details

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. In the era of molecular medicine, biomarkers usually mean molecular biomarkers and can be divided into 3 broad categories Scope of the Report: This report focuses on the N

View Details

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. Scope of the Report: This report focuses on the Tyrosine Kinase JAK Inhibitors in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market base

View Details

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Kohler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological re

View Details

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Scope of the Report: This report focuses on the Human Milk Oligosaccharides (HMO) in Global market, especially

View Details

According to Stratistics MRC, the Global Cell Expansion market is expected to grow from $8.57 billion in 2016 to reach $28.30 billion by 2023 with a CAGR of 18.6%. Rising high prevalence of chronic diseases, increasing government funding for research, soaring company investments for the development of cell-based products and technological advancements in cell expansion techniques are the major factors driving the market growth. However, high cost of operation required for cell expansion techniqu

View Details

According to Stratistics MRC, the Global Cancer Immunotherapy market is estimated at $62.57 billion in 2016 and is expected to reach $160.24 billion by 2023 growing at a CAGR of 14.3% from 2016 to 2023. Rapid increase in cases of cancer across the globe, technical advancement in treatment therapies, smoking and excessive consumption of alcohol which causes cancer are some of the factors fueling the market growth. High cost for the treatment and lack of awareness are the restraints hampering the

View Details

According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $310.0 million in 2016 to reach $1201.52 million by 2023 with a CAGR of 21.3%. Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulation

View Details

According to Stratistics MRC, the Global Genotyping market is estimated at $8.64 billion in 2016 and is expected to reach $31.19 billion by 2023 growing at a CAGR of 20.1% from 2016 to 2023. Growing awareness regarding personalized medicine and genetic diseases among the people, increase in target diseases occurrence and technological improvements in genotyping are the key factors driving the market growth. On the other hand, poor reimbursement policies are hampering the market growth. Demand fo

View Details

According to Stratistics MRC, the Global Stem Cell Banking Market is accounted for $1.68 billion in 2016 and is expected to reach $5.61 billion by 2023 growing at a CAGR of 18.8% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential

View Details

According to Stratistics MRC, the Virus Filtration Market is accounted for $2.22 billion in 2016 and expected to grow at a CAGR of 13.7% to reach $5.46 billion by 2023. Factors like stipulation for biological products, increasing investment in R&D, prevalence of chronic diseases, presence of a large genome pool are boosting the market growth. However, intense competition among vendors and stringent regulations for validation of filtration products are restraining the market growth. Increasing ph

View Details

According to Stratistics MRC,the Global Epigenetics Market is accounted for $752.8 million in 2016 and expected to grow at a CAGR of 14.0% to reach $1891.9 million by 2023. Growing prevalence of cancer and other chronic diseases are helping the market to compete across the globe. Some of the major factors that are influencing the market include growing technological advancements, rising R&D expenditure, growing usage for non-oncology diseases, improving collaborations between pharmaceutical, bio

View Details

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl